Sign in to view content

Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker for the Treatment of Diabetic Macular Edema

Victor Hugo Gonzalez, MD

Video
Published 2024

Related

Cystoid Macular Edema after Retinectomy for Proliferative Vitreoretinopathy
Yodpong Chantarasorn, MD
On Demand Cases, Courses, and Papers
2019
Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD
Peter A. Campochiaro, MD
Updates from the Field
2020
Episode 14: Plasma VEGF Levels After Anti-VEGF Injections (DRCR protocol T) with Dr. Charles Wykoff
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018

Category: Diabetic Retinopathy

See more